Chemist Warehouse's parent company Sigma Healthcare reported its half-year result today. Photo / Warren Buckland
Chemist Warehouse's parent company Sigma Healthcare reported its half-year result today. Photo / Warren Buckland
Retail pharmacy chain Chemist Warehouse has reported a lift in sales for its New Zealand business over the first half and revealed plans for further expansion.
Sigma Healthcare, parent company of Chemist Warehouse, reported its results for the six months ended December 31, 2025. It represents the first result forthe group following its reverse acquisition in February 2025.
Within the result, Chemist Warehouse New Zealand reported sales growth of 22.4% for the half.
Store count in New Zealand has grown rapidly since 2020, with the total number of stores increasing from 14 in the 2020 financial year to 70 in 2025, with nine stores opening in the second half of last year.
No specific revenue figure was listed, with New Zealand’s total included as part of the larger international contingent, which includes China, Ireland and the United Arab Emirates, who have a combined 27 stores.
The wider international contingent’s revenue lifted by 24.5% to $807 million, with like-for-like sales growth of 11.1%.
Sigma Pharmaceuticals chief executive Vikesh Ramsunder said on the company’s investor call that the New Zealand segment planned to open a further four stores in the second half of the year.
Ramsunder also said the strength of the New Zealand business had triggered a review of its supply chain requirements, revealing the company has almost finalised plans for a new distribution centre in Auckland.
Sigma Healthcare has been approached for comment on the result.
Tom Raynel is a multimedia business journalist for the Herald, covering small business, retail and tourism.
Stay ahead with the latest market moves, corporate updates, and economic insights by subscribing to our Business newsletter – your essential weekly round-up of all the business news you need.
